List of insiders holdings for Vigil Neuroscience Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Vitorovic Stefan Director | 2023-06-09 16:09:28 | 13,928 5,015,929 | 5,029,857 | Form 4 |
| Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 2023-02-10 16:31:51 | 5,015,929 0 | 5,015,929 | Form 13D |
| Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 2022-01-21 16:39:21 | 4,808,896 0 | 4,808,896 | Form 13D |
| Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 2022-12-16 17:22:58 | 4,214,498 0 | 4,214,498 | Form 13D |
| AMGEN INC 10% Owner | 2022-01-11 21:33:29 | 3,206,281 0 | 3,206,281 | Form 13G |
| Thorp Clay Director | 2022-05-17 21:06:52 | 3000 1,556,030 | 1,559,030 | Form 4 |
| Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund IV LP Former 10% Owner | 2022-01-13 16:06:53 | 0 616,786 | 616,786 | Form 4 |
| Magovcevic-Liebisch Ivana President and CEO | 2024-03-01 17:53:26 | 463,000 0 | 463,000 | Form 4 |
| Kaufmann Petra Chief Medical Officer | 2024-03-20 16:07:04 | 330,000 0 | 330,000 | Form 4 |
| Silber Christopher Chief Medical Officer | 2023-08-07 18:43:55 | 330,000 0 | 330,000 | Form 4 |
| Alexandria Venture Investments LLC 10% Owner | 2022-01-11 17:53:24 | 192,973 0 | 192,973 | Form 4 |
| Ziolkowski Jennifer Lynn Chief Financial Officer | 2024-03-01 18:00:01 | 156,000 0 | 156,000 | Form 4 |
| Papapetropoulos Spyros Chief Medical Officer | 2022-11-22 21:45:28 | 153,604 0 | 153,604 | Form 4 |
| Gray David L. F. Chief Science Officer | 2024-03-01 17:50:37 | 125,000 0 | 125,000 | Form 4 |
| Verni Christopher General Counsel | 2024-03-01 18:08:18 | 116,000 0 | 116,000 | Form 4 |
| Thackaberry Evan SVP, Head of Early Development | 2023-03-03 17:08:53 | 65,000 0 | 65,000 | Form 4 |
| Booth Bruce Director | 2024-03-05 18:57:07 | 34,612 0 | 34,612 | Form 4 |
| Blanchard Cheryl R Director | 2024-03-05 17:57:53 | 24,761 0 | 24,761 | Form 4 |
| Bruhn Suzanne Louise Director | 2024-03-05 18:01:13 | 24,073 0 | 24,073 | Form 4 |
| Budd Haeberlein Samantha L. Director | 2023-06-09 16:06:07 | 13,928 0 | 13,928 | Form 4 |
| Koenig Gerhard Director | 2023-06-09 16:10:30 | 13,928 0 | 13,928 | Form 4 |
| Thistle Mary Director | 2023-06-09 16:13:10 | 13,928 0 | 13,928 | Form 4 |
| Gandhi Shaan-Chirag C Director | 2022-01-06 20:26:30 | 0 0 | 0 | Form 3 |